体外診断におけるeコマースビジネスモデルの成長機会

COVID-19は、体外診断（IVD）を含むヘルスケアのデジタル化を加速させました。また、技術革新は、世界な接続性、透明性、アクセス、拡張性、コスト効率に重点を置いた、診断分野における新たなeコマースプラットフォームソリューションの機会を提供します。

当レポートでは、世界の体外診断におけるeコマースビジネスモデルについて調査分析し、戦略的必須要件、成長機会、競合環境、各種使用事例等の情報を提供しています。

目次

戦略的必須要件

成長機会分析

• 調査の目的と調査手法
• 体外診断におけるeコマース業界情勢
• 市場セグメンテーション
• 成長促進要因
• 成長抑制要因

マクロからミクロの体外診断におけるeコマースビジネスモデル

• マクロからミクロへのビジョン
• 患者、医療提供者、医師の間でのテクノロジーの導入
• 業界を超えた協業により、業界関係者は潜在的なパートナーシップの機会を探ることができる
• 業界間の相互接続性は、B2BおよびB2C市場の力の乗数として機能する

サプライチェーン参加者と使用

• 優先チャネルと戦略的優先事項
• 優先チャネル : 診断デバイスタイプ別
• 優先チャネル : ソリューション・サービスのタイプ別
• 市場の魅力とパートナーシップの機会

体外診断におけるB2B・B2B2C向けeコマース - 競合環境、需要と供給の問題点、戦略、および使用事例

• IVDとeコマース市場における競合環境
• B2B向けeコマースの需要と供給チャネルの問題点
• 体外診断におけるeコマース業界参加者の戦略
• 流通バリューチェーン出資者にとってのB2B向けサプライチェーン市場の利点
• 使用事例 - Abbott Diagnostics
• 使用事例 - Siemens Healthineers
• 使用事例 - Thermo Fisher Scientific Corporation
• 使用事例 - LabX
• 使用事例 - KWIPPED

研究開発の供給と使用事例

• 研究開発サプライチェーン - オンラインプラットフォームが市場機会を約束
• 使用事例 - ZAGENO, Inc.
• 使用事例 - Science.com
• 使用事例 - Wazoku

B2C向けデジタル/eファーマシー - 競合環境、問題点、戦略、および使用事例

• B2C向けデジタル/eファーマシーにおける競合環境
• B2C向けデジタル/eファーマシー業者の問題点
• B2C向けデジタル/eファーマシー業界参加者の戦略
• B2C向けデジタル/eファーマシーは、顧客中心の付加価値をつけたサービスと製品を提供する
• 使用事例 - Amazon Pharmacy
• 使用事例 - CVS Pharmacy
• ケーススタディ - Walgreens Boots Alliance
• 結論

成長機会ユニバース

• 成長機会1 - 拡張性の高い顧客体験のためのテクノロジー対応eコマースサプライチェーン
• 成長機会2 - 研究開発eコマース市場は機会を切り拓き、研究者と科学者のコストと時間を最適化する
• 成長機会3 - 包括的疾病管理のためのテレファーマシーサービス

付録

• eコマースとeビジネスの違い
• ビジネスモデルの転換
• 展示物一覧
• 免責事項

Disruptive Differentiation in Supply Chain Management Drives New Growth Potential

Diagnostics are central to healthcare, but not accessible to all. A 2020 Lancet study states that 47% of the global population has little to no access to accurate diagnostics, emphasizing the need for equitable distribution across geographies and containing procurement costs. The COVID-19 pandemic increased demand for personal protective equipment, consumables for molecular diagnostics, vaccines, and POCT testing for SARS-Cov2. However, serious glitches in supply and logistics due to poor procurement strategies led to manufacturing delays and a surge in diagnostics and healthcare costs. Vendors of R&D prototyping, small-batch manufacturing services, and niche testing labs recorded the largest revenue drop across the value chain. The coronavirus also accelerated healthcare digitalization, including in vitro diagnostics (IVD).

Engineering and technological innovations present opportunities to create new eCommerce platform solutions in the diagnostics segment, emphasizing global connectivity, transparency, access, scalability, and cost efficiencies. These features reduce the gaps in the IVD industry, improve access, and democratize diagnostics to empower providers, payers, and patients. Lessons learned from the pandemic in 2020 and 2021 serve as the building blocks to strengthen healthcare systems, primarily timely health service delivery, attention to the healthcare workforce, need for robust health information systems, access to diagnostics (analogous to essential medicines), efficient supply chain for procurement and supplies, and seamless communication and interconnectedness, financing, leadership, and governance. eCommerce marketplaces for healthcare and IVD provide an opportunity to buy, sell, lease, market, and procure diagnostic products and service information on any internet device, such as the computer (web-based) or mobile (mCommerce). Pharmaceuticals, biotech companies, contract research organizations, hospitals, clinics, universities, laboratories, government, and customers can use these technology platforms to access the global ecosystem. While technology infrastructure within eCommerce is evolving, essential technologies enabling healthcare transactions include EDI, bar codes, cloud, product data exchange, and electronic forms. This study assesses the eCommerce business potential across sectors, creating resilient healthcare and diagnostic market opportunities for R&D, manufacturing, and supply chain functions. It explores other scalable, cost-efficient business opportunities with new B2B products, customized outsourcing services, and technology-enabled tools for efficiency and ease of operations. The IVD market is buoyant due to the soaring demand for products, molecular diagnostics, immunoassays, and POCT in chronic diseases. The rise in consumerization, telehealth, and ePharmacy also push it toward further digitalization with advanced artificial intelligence, machine learning, and the internet of things technologies. The study also examines the competitive environment, strategies, market models, and use cases for success in the IVD eCommerce platform industry.

Table of Contents

Strategic Imperatives

• Why is it Increasingly Difficult to Grow?
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on the In Vitro Diagnostic eCommerce Platform Industry
• Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

• Research Objective and Methodology
• In Vitro Diagnostic Ecommerce Industry Landscape
• Market Segmentation
• Growth Drivers
• Growth Drivers (continued)
• Growth Restraints
• Growth Restraints (continued)

Macro to Micro In Vitro Diagnostic eCommerce Business Model

• Macro to Micro Visioning
• Technology Adoption Among Patients, Providers, and Physicians
• Cross-sector Collaborations Encourage Industry Players to Explore Potential Partnership Opportunities
• Cross-sectoral Interconnectedness Acts as a Force Multiplier for B2B and B2C Markets

Supply Chain Participants and Use

• Preferred Channels and Strategic Priorities
• Preferred Channels and Strategic Priorities (continued)
• Preferred Channels and Strategic Priorities (continued)
• Preferred Channel by Diagnostic Device Type
• Preferred Channel by Solutions and Service Types
• Market Attractiveness and Partnership Opportunity

IVD B2B, B2B2C eCommerce-Competitive Environment, Supply-Demand Pain Points, Strategies, and Use Cases

• Competitive Environment-IVD and eCommerce Marketplace
• Competitive Environment-IVD and eCommerce Marketplace (continued)
• B2B eCommerce Supply and Demand Channel Pain Points
• Strategies of IVD eCommerce Industry Participants
• Strategies of IVD eCommerce Industry Participants (continued)
• Strategies of IVD eCommerce Industry Participants (continued)
• Strategies of IVD eCommerce Industry Participants (continued)
• Strategies of IVD eCommerce Industry Participants (continued)
• B2B Supply Chain Marketplace Benefits for Distribution Value Chain Stakeholders
• Use Case-Abbott Diagnostics
• Use Case-Siemens Healthineers
• Use Case-Thermo Fisher Scientific Corporation
• Use Case-LabX
• Use Case-KWIPPED

R&D Supply and Use Cases

• R&D Supply Chain-Online Platform Promises Market Opportunities
• Use Case-ZAGENO, Inc.
• Use Case-Science.com
• Use Case-Wazoku

B2C Digital/ePharmacyUse Case-WazokuCompetitive Environment, Pain Points, Strategies, and Use Cases

• Competitive Environment-B2C Digital/ePharmacy
• Pain Points of B2C Digital/ePharmacy Providers and Suppliers
• Strategies of B2C Digital/ePharmacy Industry Participants
• Strategies of IVD B2C Digital/ePharmacy Industry Participants (continued)
• B2C Digital/ePharmacy Offers Customer-centric Value-added Services and Products
• Use Case-Amazon Pharmacy
• Use Case-CVS Pharmacy
• Case Study-Walgreens Boots Alliance
• Conclusion

Growth Opportunity Universe

• Growth Opportunity 1-Technology-enabled eCommerce Supply Chain for Scalability Enhanced Customer Experience
• Growth Opportunity 1-Technology-enabled eCommerce Supply Chain for Scalability and Enhanced Customer Experience (continued)
• Growth Opportunity 2-R&D eCommerce Marketplace Opens Opportunities and Optimizes Cost and Time for Researchers and Scientists
• Growth Opportunity 2-R&D eCommerce Marketplace Opens Opportunities and Optimizes Cost and Time for Researchers and Scientists (continued)
• Growth Opportunity 3-Telepharmacy Services for Comprehensive Disease Management
• Growth Opportunity 3-Telepharmacy Services for Comprehensive Disease Management (continued)

Appendix

• The Difference Between eCommerce and eBusiness
• Business Model Shift
• Business Model Shift (continued)
• List of Exhibits
• Legal Disclaimer